FDA Approves Talazoparib With Enzalutamide For Metastatic Androgen Pathway Modulation-Naive Or -Sensitive Prostate Cancer With Hrr Gene Mutations

Benzinga · 1d ago

https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-talazoparib-enzalutamide-metastatic-androgen-pathway-modulation-naive-or-sensitive